Geron GERN
NASDAQ GERN
$1.16 -0.08 (-6.45%)
At close: Oct 21, 2026 · 4:00 PM EDT

Geron (GERN) Equity Income (2010 - 2011)

Updated

Geron (GERN) recorded Equity Income of -$503,000 in FY2011, compared with -$2.35 million in FY2010.

Analysis

Geron (GERN) Equity Income (2010 - 2011) Analysis & Trends

  • Per Business Quant data, GERN's Equity Income was -$2.35 million in FY2010 and -$1.34 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -10.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Geron 763.84 Mn -587.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 -168,000.00
Mar 31, 2011 -335,000.00
Dec 31, 2010 -1.21 Mn
Sep 30, 2010 -243,000.00
Jun 30, 2010 -496,000.00
API Access

Geron Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=GERN&period=max&api_key=YOUR_API_KEY